Updated on 30 July 2015
Over 3000 attendees and 150 exhibitors from an estimated 50 countries are set to gather in South Korea for the event
Singapore: Co-organised by the Korean Pharmaceutical Traders Association and the UBM EMEA, CPhl Korea will be held in Seoul from September 7 to 9, 2015 along with three other events- ICSE, P-MEC and BioPh. The four events held together is expected to attract pharma and biotech giants from across Asia and the globe.
The event plays a pivotal role in bringing together pharma companies and executives from across Asia and the globe, and provides an unrivalled central hub for creating business opportunities and partnerships.
The three day event has an exhibition phase three times larger than the previous year. Over 3000 attendees and 150 exhibitors from an estimated 50 countries are set to gather in South Korea for the event.
With increased government support and reforms, investments in South Korean pharma and biotech industry have increased in the past few years. The Korean government has committed $8.9 billion to drug development over the next five years. Also currently, South Korea has the largest number of biosimilar clinical trials and targets in its pipeline, making it the global leader for development of biologic drugs.